tm
Seeing Is Believing
tm
Seeing Is Believing
GRCL is currently covered by 7 analysts with an average price target of $15.22. This is a potential upside of $4.97 (48.49%) from yesterday's end of day stock price of $10.25.
Gracell Biotechnologies's activity chart (see below) currently has 6 price targets and 20 ratings on display. The stock rating distribution of GRCL is 58.33% BUY and 41.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 31.67% with an average time for these price targets to be met of 87.5 days.
Highest price target for GRCL is $10, Lowest price target is $2, average price target is $8.67.
Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 27-Dec-2023. First documented stock forecast 30-Apr-2021.
Currently out of the existing stock ratings of GRCL, 7 are a BUY (58.33%), 5 are a HOLD (41.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$-0.25 (-2.44%)
$10
1 years 2 months 14 days ago
(27-Dec-2023)
2/5 (40%)
$0.08 (0.81%)
292
Hold
$10
$-0.25 (-2.44%)
$7
1 years 2 months 14 days ago
(27-Dec-2023)
2/2 (100%)
$0.08 (0.81%)
138
Hold
$10
$-0.25 (-2.44%)
$13
1 years 2 months 15 days ago
(26-Dec-2023)
2/4 (50%)
$0.08 (0.81%)
95
Hold
$20
1 years 2 months 15 days ago
(26-Dec-2023)
0/1 (0%)
$13.93 (229.49%)
Buy
$11
$0.75 (7.32%)
1 years 4 months 22 days ago
(19-Oct-2023)
0/2 (0%)
$8.24 (298.55%)
What is GRCL (Gracell Biotechnologies) average time for price targets to be met?
Which analyst has the current highest performing score on GRCL (Gracell Biotechnologies) with a proven track record?
Which analyst has the current lower performing score on GRCL (Gracell Biotechnologies) with a proven track record?
Which analyst has the most public recommendations on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most bullish on GRCL (Gracell Biotechnologies)?
Which analyst is the currently most reserved on GRCL (Gracell Biotechnologies)?
